The recent announcement by GlaxoSmithKline (GSK) that it will make the structures of over 13,500 compounds from its antimalarial screening programme publicly available is another welcome example of a ...
The retrovirus HIV-1 is one of the world's most intensively studied pathogens. Although the effective control of this infectious agent has been difficult to achieve, particularly in developing nations ...